Nav: Home

Cluster of factors could help predict C. diff

October 24, 2018

COLUMBUS, Ohio - A cluster of factors may help predict which patients are likely to develop Clostridioides difficile, a potentially life-threatening disease commonly known as C. difficile or C. diff, a new study has found.

And that could help in efforts to prevent infection, according to the researchers.

Reduced immune function, recent antibiotic use, current or recent hospitalization and prior C. difficile infection predicted risk of subsequent infection, opening the door to potential preventive interventions.

"This could help health care providers red-flag those patients who are at high risk of C. diff, and may one day lead to therapeutic or dietary tactics to lower the chances of infection," said the study's co-lead author, Vanessa Hale of The Ohio State University.

The study appears in the journal Science Translational Medicine.

The research included studies in both humans and mice, and involved the transplant of feces from human study participants to mice to assess differences in susceptibility to C. difficile infection and molecular-level explanations for that increased risk.

"Microbes in the gut play a critical role in defending against disease, and the really exciting part of this study is that it might help us better identify the risk factors that are linked to problems in the gut and susceptibility to these dangerous infections," said Hale, an assistant professor of veterinary preventive medicine at Ohio State. The study was conducted at the Mayo Clinic, where she previously worked.

The researchers started by looking at the gut microbes of a group of 115 people who had diarrhea but who did not have C. diff when they first sought medical care, some of whom went on to develop a C. diff infection. They also analyzed the gut microbes of 118 healthy volunteers for comparison.

"About half of the diarrhea patients had gut microbial communities that looked healthy, but the guts of the other half were really intriguing - they had different microbes and very different levels of metabolites. We called this half the 'dysbiotic' - or unhealthy - group," Hale said.

"When we transplanted human stool from the dysbiotic group into mice, we discovered that these mice were more likely to become infected with C. diff than mice that received human stool from the healthy-looking group."

The researchers then examined potential risk factors found on the medical charts of individuals with "dysbiotic" and healthy-looking gut microbial communities and found a cluster of five factors that were associated with unhealthy communities.

"We knew that dysbiotic microbial communities put mice at higher risk of C. diff infection, and we wanted to see if the five factors could be used to predict C. diff infections in humans," Hale said.

To do this, the research team went back and looked at the medical charts of more than 17,000 previous patients who were free of C. diff when they initially sought care. In that larger group, there also was a clear connection between the risk factors and subsequent C. diff infection.

Furthermore, the researchers found higher levels of amino acids - particularly proline - in the guts of mice that received transplants from people whose gut microbiomes were unhealthy, or dysbiotic.

That was interesting, and potentially important, because C. diff needs amino acids like proline to proliferate and it cannot make proline on its own. That prompted the team to wonder if reducing dietary amino acids could protect against C. diff, Hale said.

Feeding the mice diets low in protein moderately lowered the growth of C. diff, providing further evidence that amino acids - including proline - play a role in risk of infection and leaving researchers curious about the potential for dietary interventions in at-risk humans, Hale said.

"It's possible that a dietary strategy could reduce C. diff infection in those patients who are deemed to be susceptible based on the cluster of risk factors we identified," she said, adding that more study is needed to understand that relationship.

The study also showed that prophylactic fecal transplantation from a healthy donor could protect against C. diff in mice that were initially prone to infection.

"The transplants were fully protective against C. diff infection in all of the animals we tested, which was pretty amazing," Hale said.

The U.S. Food and Drug Administration currently allows fecal transplantation for treatment of recurrent C. diff in individuals who do not respond to conventional therapies - primarily antibiotics. However, it is unlikely that fecal transplantation would quickly be adopted as a prevention strategy in those deemed to be at elevated risk of infection, Hale said.
-end-
The National Institutes of Health and the Center for Individualized Medicine at Mayo Clinic supported the study.

Eric Battaglioli of Georgetown College was the co-lead author. Purna Kashyap of Mayo Clinic is the senior author.

CONTACT: Vanessa Hale, 614-247-8377; Hale.502@osu.edu

Written by Misti Crane, 614-292-5220; Crane.11@osu.edu

VIDEO, COURTESY OF THE MAYO CLINIC: https://bit.ly/2OPMO3e

Ohio State University

Related Amino Acids Articles:

A unique amino acid for brain cancer therapy
Researchers discover potential application of amino acid taurine in photodynamic therapy for brain cancer.
Nickel: A greener route to fatty acids
Chemists designed a nickel catalyst that easily transforms petroleum feedstocks into valuable compounds like fatty acids.
Amino acids in diet could be key to starving cancer
Cutting out certain amino acids - the building blocks of proteins -- from the diet of mice slows tumor growth and prolongs survival, according to new research published in Nature.
How to brew high-value fatty acids with brewer's yeast
Researchers at Goethe University Frankfurt have succeeded in producing fatty acids in large quantities from sugar or waste containing sugar with the help of yeasts.
Diverse natural fatty acids follow 'Golden Mean'
Bioinformatics scientists at Friedrich Schiller University in Jena (Germany) have discovered that the number of theoretically possible fatty acids with the same chain length but different structures can be determined with the aid of the famous Fibonacci sequence.
Simple fats and amino acids to explain how life began
Life is a process that originated 3.5 billion years ago.
Newly revealed amino acid function could be used to boost antioxidant levels
A Japanese research team has become the first in the world to discover that 2-aminobutyric acid is closely involved in the metabolic regulation of the antioxidant glutathione, and that it can effectively raise levels of glutathione in the body when ingested.
An amino acid controls plants' breath
IBS plant scientists demonstrate that the amino acid L-methionine activates a calcium-channel regulating the opening and closing of tiny plant pores.
Genetic differences in amino acid metabolism are linked to a higher risk of diabetes
A study published today in the journal PLOS Medicine has identified the five genetic variants associated with higher levels of the branched-chain amino acids isoleucine, leucine and valine.
Withholding amino acid depletes blood stem cells, Stanford researchers say
A new study shows that a diet deficient in valine effectively depleted the blood stem cells in mice and made it possible to perform a blood stem cell transplantation on them.

Related Amino Acids Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...